So we need followup human testing. WHOM IS YOUR STROKE HOSPITAL CONTACTING TO GET THAT DONE? NOTHING? Then I sugget firing the whole hospital starting with the board of directors. This would be better said, 'This stops one of the causes of the neuronal cascade of death in the first week.' Neuroprotection doesn't specify urgency, CASCADE OF DEATH does
Nix Plays a Neuroprotective Role in Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats
- Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, China
Nix is located in the outer membrane of mitochondria,
mediates mitochondrial fission and implicated in many neurological
diseases. However, the association between Nix and subarachnoid
hemorrhage (SAH) has not previously been reported. Therefore, the
present study was designed to evaluate the expression of Nix and its
role in early brain injury (EBI) after SAH. Adult male Sprague-Dawley
(SD) rats were randomly assigned to various time points for
investigation after SAH. A rat model of SAH was induced by injecting 0.3
ml of autologous non-heparinized arterial blood into the prechiasmatic
cistern. The expression of Nix was investigated by Western blot and
immunohistochemistry. Next, Nix-specific overexpression plasmids and
small interfering RNAs (siRNAs) were separately administered. Western
blot, neurological scoring, Morris water maze, terminal deoxynucleotidyl
transferase-mediated dUTP nick end labeling (TUNEL) staining and
fluoro-jade B (FJB) staining were performed to evaluate the role of Nix
in EBI following SAH. We found that Nix was expressed in neurons and its
expression level in the SAH groups was higher than that in the Sham
group, which peaked at 24 h after SAH. Overexpression of Nix following
SAH significantly decreased the expression of translocase of outer
mitochondrial membrane 20 (TOMM20, a marker of mitochondria),
ameliorated neurological/cognitive deficits induced by SAH, and reduced
the total number of apoptotic/neurodegenerative cells, whereas siRNA
knockdown of Nix yielded opposite effects. Taken together, our findings
demonstrated that the expression of Nix is increased in neurons after
experimental SAH in rats, and may play a neuroprotective role in EBI
following SAH.
Introduction
Spontaneous subarachnoid hemorrhage (SAH) is a
cerebrovascular disease with high disability and mortality rates.
Rupture aneurysm is the main cause of SAH, accounting for about 85% of
all spontaneous SAH (Ji and Chen, 2016).
Although great progress has been made in current treatment of
intracranial aneurysms, including microsurgery and endovascular
embolization, it is reported that the disability and mortality rates of
SAH have still not significantly decreased. The mortality rate of SAH is
between 25 and 35% in high-income countries, and is as high as 48% in
low-income countries (Pluta et al., 2009).
Early brain injury (EBI) is an important factor leading to the
deterioration of SAH patients. The occurrence of EBI after SAH is a
complex pathophysiological process, and its mechanisms may be related to
autophagy, apoptosis, inflammation, destruction of the blood-brain
barrier (BBB), cytotoxic brain edema and oxidative stress (Fujii et al., 2013).
Therefore, there is an urgent need for continued scientific
investigations of novel approaches for preventing and treating EBI after
SAH.
Autophagy involves the identification of cellular
proteins and organelles for degradation that are then wrapped by double
layered membranous structures that are detached from the ribosome-free
attachment region of the rough-surface endoplasmic reticulum (ER) to
form autophagosomes; subsequently, autophagosomes are further degraded
after being fused with lysosomes, to meet the metabolic demands of cells
and to regenerate organelles as needed (Nah et al., 2015).
Studies have shown that mitochondrial dysfunction affects a series of
intracellular biological processes that are involved in the process of
EBI after SAH, including oxidative damage, calcium homeostasis disorder,
and the collapse of ATP synthesis (Li et al., 2018).
Mitophagy is the process in which injured or unwanted mitochondria are
selectively cleared via autophagy, thereby maintaining the homeostasis
of cells (Liu et al., 2014). Taken together, mitophagy may play an important role during EBI after SAH.
Nix, also known as B-cell lymphoma 2 (Bcl-2)-interacting
protein 3 like (Bnip3L), was originally thought to belong to the Bcl-2
family and BH3-only pro-apoptotic proteins, but its ability to induce
apoptosis was found to be weak (Sandoval et al., 2008; Zhang and Ney, 2009).
With the development of further research, it has been found that Nix is
different from other typical BH-3-only proteins and that pro-apoptosis
may not be its main function (Mellor and Harris, 2007; Ding et al., 2010).
Nix was first described as a mitophagic receptor when it was discovered
to be involved in the procedural clearance of mitochondria during
reticulocyte maturation (Ney, 2015).
In recent years, it has been considered that the mechanisms of EBI
after SAH are complex, which are the result of a combination of various
factors. Although recent studies have suggested that autophagy is
activated after SAH and can ameliorate EBI, the specific mechanism
underlying this process remains unknown (Li et al., 2014).
As mitochondria are the most important organelles for sources of
intracellular energy, mitochondrial dysfunction plays a significant role
in EBI after SAH (Wang et al., 2017; Zhou et al., 2017).
Mitophagy clears impaired mitochondria in cells. Hence, discovery of
the key factors that regulate the occurrence of mitophagy after SAH may
reverse brain injury caused by mitochondrial dysfunction (Chen et al., 2014).
Nix is located on the outer mitochondrial membrane and has been
demonstrated to be a vital protein for regulating mitophagy. Moreover,
Nix has been shown to be involved in the pathophysiological processes of
various central nervous system (CNS) diseases, including cerebral
ischemia-reperfusion (I/R) injury, intracranial hemorrhage, spinal cord
injury and neurodegenerative diseases; however, the specific mechanisms
of Nix in the pathophysiology of these CNS diseases remain unclear (Rui et al., 2013; Yu et al., 2013; Park et al., 2017; Yuan et al., 2017).
In the present study, we determined the expression of Nix
after SAH, and further investigated the role of Nix in EBI after SAH.
Our findings elucidating the role of Nix in EBI after SAH may provide a
novel approach of thought for the treatment of SAH patients.
No comments:
Post a Comment